References
1. Yap HY, Yap BS, Tashima CK, et al. Meningeal carcinomatosis in breast cancer. Cancer 1978;42:283–286.
2. Rosen ST, Aisner J, Makuch RW, et al. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore)1982;61:45–53.
3 . Aroney RS, Dalley DN, Chun WK, et al. Meningeal cancer in small cell carcinoma of the lung. Am J Med 1981;7:26–32.
4. Amer MH, Al-Sarraf M, Baker LH, et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978;42:660–668.
5. Chamberlain MC. Carcinomatous meningitis. Arch Neurol 1997;54:16–17.
6. Bruna J, Rojas-Marcos I, Martínez-Yelamos S, et al. Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder. J Neurooncol 2003;63:63–67.
7. Cozzarini C, Reni M, Mangili F, et al. Meningeal carcinomatosis from transitional cell carcinoma of the bladder: report of two cases and review of the literature. Cancer Invest 1999;17:402–407.
8. Eng C, Cunningham D, Quade BJ, et al. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer 1993;72:553–557.
9. Juan Vidal O, de Paz Arias L, Catalá Barceló J, et al. Meningeal carcinomatosis as first manifestation of carcinoma of the bladder: report of 2 cases [in Spanish]. An Med Interna 2000;17:425–428.
10. Loizaga Iriarte A, Arciniega García JM, Infante Riaño R, et al. Meningeal carcinomatosis in bladder tumor [in Spanish]. Actas Urol Esp 1999;23:873–875.
11. Bloch JL, Nieh PT, Walzak MP. Brain metastases from transitional cell carcinoma. J Urol 1987;137:97–99.
12. Hust MH, Pfitzer P. Cerebrospinal fluid and metastasis of transitional cell carcinoma of the bladder. Acta Cytol 1982;26:217–223.
13. Hasbini A, Himberlin C, Beguinot I, et al. La meningite carcinomateuse: une complication rare du cancer de la vessie. Rev Med Interne 1997;18:402–406.
14. Hussein AM, Savaraj N, Feun LG, et al. Carcinomatous meningitis from transitional cell carcinoma of the bladder: case report. J Neurooncol 1989;7:255–260.
15. Imamura S, Nozawa I, Imamura M, et al. Clinicopathologic study of leptomeningeal carcinomatosis involving the temporal bone. Ann Otol Rhinol Laryngol 1997;106:674–679.
16. Mandell S, Wernz J, Morales P, et al. Carcinomatous meningitis from transitional cell carcinoma of bladder. Urology 1985;25:520–521.
17. Santarossa S, Vaccher E, Balestreri L, et al. Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation. J Neurooncol 1997;35:141–143.
18. Steg RE, Frank AR, Lefkowitz DM. Complex partial status epilepticus in a patient with dural metastases. Neurology 1993;43:2389–2392.
19. Bishop JR Jr, Moul JW, Maldonado L, et al. Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) chemotherapy. Urology 1990;36:373–377.
20. Raghavan D, Chye RW. Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder. Br J Urol 1991;67:438–440.
21. Sugimori K, Kobayashi K, Hayashi M, et al. Leptomeningeal carcinomatosis from urinary bladder adenocarcinoma: a clinicopathological case study. Neuropathology 2005;25:89–94.
22. Chamberlain MC. Neoplastic meningitis. Oncologist 2008;13:967–977.
23. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759–772.
24. Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996;53:626–632.
25. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103–119.